Contortrostatin activates ERK2 and tyrosine phosphorylation events via distinct pathways

Citation
Mr. Ritter et Fs. Markland, Contortrostatin activates ERK2 and tyrosine phosphorylation events via distinct pathways, BIOC BIOP R, 274(1), 2000, pp. 142-148
Citations number
35
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
274
Issue
1
Year of publication
2000
Pages
142 - 148
Database
ISI
SICI code
0006-291X(20000721)274:1<142:CAEATP>2.0.ZU;2-C
Abstract
We report that cells adhering to contortrostatin show transient increases i n activation of Extracellular signal Regulated Kinase 2 (ERK2). The kinetic s and degree of activation are similar to cells adhering to fibronectin or vitronectin. We have recently shown that contortrostatin induces tyrosine p hosphorylation in tumor cells. Contortrostatin is shown here to stimulate a ctivation of ERK2 in suspended cells, but this activation follows a differe nt dose-response pattern than contortrostatin-induced tyrosine phosphorylat ion. Since contortrostatin induces tyrosine phosphorylation via alpha v bet a 3, we explored the effects of an alpha v beta 3-blocking antibody, 7E3, o n contortrostatin-stimulated ERK2 activation. While 7E3 completely blocks t he effect of contortrostatin on tyrosine phosphorylation, this antibody had no effect on activation of ERK2. In cells lacking expression of alpha v be ta 3, tyrosine phosphorylation was unaffected by contortrostatin treatment, but ERK2 was activated. This is strong evidence that contortrostatin is re gulating tyrosine phosphorylation events and ERK2 activation via separate p athways and through different integrin receptors. (C) 2000 Academic Press.